“Ofatumumab: A Second Generation Anti-CD20 Monoclonal Antibody in Chronic Lymphocytic Leukemia”. Hematology Meeting Reports (formerly Haematologica Reports), vol. 3, no. 3, June 2009, https://doi.org/10.4081/hmr.v3i3.583.